World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 99 743 682 424 382 299 41147
Medicine 99 8515 8002 4391 4062 301 41149

Robert H. Vonderheide publications per year

The chart shows the history of publications by Robert H. Vonderheide between 1988 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Robert H. Vonderheide published across 39 years, from 1988 to 2026, averaging 19.5 papers a year. Output peaked at 300 publications in 2023. 53 of the 759 publications appeared in the last two years.

No. of publications
100 200 300
Bar chart. Horizontal axis: year, 1988 to 2026. Vertical axis: number of publications, 0 to 300. Peak 300 publications in 2023. 1988: 1 publication 1989: 0 publications 1990: 3 publications 1991: 2 publications 1992: 1 publication 1993: 0 publications 1994: 2 publications 1995: 0 publications 1996: 0 publications 1997: 1 publication 1998: 1 publication 1999: 1 publication 2000: 4 publications 2001: 10 publications 2002: 4 publications 2003: 8 publications 2004: 5 publications 2005: 11 publications 2006: 9 publications 2007: 13 publications 2008: 5 publications 2009: 12 publications 2010: 12 publications 2011: 9 publications 2012: 12 publications 2013: 22 publications 2014: 17 publications 2015: 34 publications 2016: 21 publications 2017: 13 publications 2018: 16 publications 2019: 13 publications 2020: 11 publications 2021: 29 publications 2022: 24 publications 2023: 300 publications 2024: 80 publications 2025: 38 publications 2026: 15 publications
1988 2026

759 publications in total across all disciplines

View publications per year as a table
Robert H. Vonderheide: publications per year, 1988 to 2026
Year Publications
1988 1
1989 0
1990 3
1991 2
1992 1
1993 0
1994 2
1995 0
1996 0
1997 1
1998 1
1999 1
2000 4
2001 10
2002 4
2003 8
2004 5
2005 11
2006 9
2007 13
2008 5
2009 12
2010 12
2011 9
2012 12
2013 22
2014 17
2015 34
2016 21
2017 13
2018 16
2019 13
2020 11
2021 29
2022 24
2023 300
2024 80
2025 38
2026 15
Total 759
Download as CSV

Robert H. Vonderheide publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert H. Vonderheide sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 292–301 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111 299
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Robert H. Vonderheide D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert H. Vonderheide sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68 99
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert H. Vonderheide is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine with an emphasis on oncology, immunology, molecular biology, and cancer research. Their extensive work spans key areas such as cancer immunotherapy, biomarkers, pancreatic and hepatic oncology, immune responses, and cancer genomics.

Their recent published papers include:

  • Challenges and Opportunities for Pancreatic Cancer Immunotherapy, 2020, Cancer Cell
  • CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer, 2021, Nature Medicine
  • Ferroptosis of tumour neutrophils causes immune suppression in cancer, 2022, Nature
  • Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer, 2022, Cancer Discovery
  • Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial, 2022, Nature Medicine

Frequent co-authors in their research collaborations include Mark H. O'Hara, Ben Z. Stanger, Katelyn T. Byrne, Nune Markosyan, and Rina Sor.

The scientist has published regularly in the following venues:

  • Cancer Research
  • Journal of Clinical Oncology
  • Cancer Immunology Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Discovery

Their work covers a variety of specialized topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Immune cells in cancer
  • Economic and Financial Impacts of Cancer

Robert H. Vonderheide has been recognized with the distinction of Member of the Association of American Physicians.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

    Christina Twyman-Saint Victor;Andrew J. Rech;Amit Maity;Ramesh Rengan;Ramesh Rengan

  • EMT and Dissemination Precede Pancreatic Tumor Formation

    Andrew D. Rhim;Emily T. Mirek;Nicole M. Aiello;Anirban Maitra

  • CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

    Gregory L. Beatty;Elena G. Chiorean;Matthew P. Fishman;Babak Saboury

  • T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

    Alexander C. Huang;Michael A. Postow;Michael A. Postow;Robert J. Orlowski;Rosemarie Mick

  • Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

    Carolyn E. Clark;Sunil R. Hingorani;Rosemarie Mick;Chelsea Combs

  • Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.

    Joseph L. Benci;Bihui Xu;Yu Qiu;Tony J. Wu

  • Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer

    Lauren J. Bayne;Gregory L. Beatty;Nirag Jhala;Carolyn E. Clark

  • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes.

    Robert H Vonderheide;William C Hahn;William C Hahn;Joachim L Schultze;Lee M Nadler

  • Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

    Jinyang Li;Katelyn T. Byrne;Fangxue Yan;Taiji Yamazoe

  • Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors

    Vinit Kumar;Laxminarasimha Donthireddy;Douglas Marvel;Thomas Condamine

  • Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody

    Robert H. Vonderheide;Keith T. Flaherty;Magi Khalil;Molly S. Stumacher

  • Challenges and Opportunities for Pancreatic Cancer Immunotherapy

    Adham S. Bear;Robert H. Vonderheide;Mark H. O'Hara

  • Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells

    Albert Lo;Liang-Chuan S. Wang;John Scholler;James Monslow

  • A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

    Gregory L. Beatty;Drew A. Torigian;E. Gabriela Chiorean;Babak Saboury

  • Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

    Rafael Winograd;Katelyn T. Byrne;Rebecca A. Evans;Pamela M. Odorizzi

  • CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.

    Erin M Bange;Nicholas A Han;Paul Wileyto;Justin Y Kim

  • Immunotherapy and Prevention of Pancreatic Cancer.

    Alexander H. Morrison;Katelyn T. Byrne;Robert H. Vonderheide

  • Agonistic CD40 Antibodies and Cancer Therapy

    Robert H. Vonderheide;Martin J. Glennie

  • Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

    Julia Tchou;Yangbing Zhao;Bruce L Levine;Paul J Zhang

Frequent Co-Authors

Rosemarie Mick
Rosemarie Mick University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Lynn M. Schuchter
Lynn M. Schuchter University of Pennsylvania
Joachim L. Schultze
Joachim L. Schultze University of Bonn
Susan M. Domchek
Susan M. Domchek University of Pennsylvania
David L. Porter
David L. Porter University of Pennsylvania
Ben Z. Stanger
Ben Z. Stanger University of Pennsylvania
Edward A. Stadtmauer
Edward A. Stadtmauer University of Pennsylvania
E. John Wherry
E. John Wherry University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students consider becoming nurse practitioners specializing in mental health or acute care to complement their understanding of immune system disorders and patient care.

Exploring the cheapest online pmhnp programs is a practical step for those seeking affordable routes into psychiatric nursing while advancing their clinical knowledge. This specialization ties closely with immunological studies related to neuroinflammation and mental health conditions.

Salaries for Nurse Practitioners can vary significantly across regions. If you are considering graduate education, reviewing the dnp salary by state will help you gauge potential earnings in the Doctor of Nursing Practice field, aligning financial prospects with your career goals.

Transitioning between specialties is also possible with online programs like the fnp to acnp bridge program online, enabling Family Nurse Practitioners to move into Acute Care Nurse Practitioner roles, which often involve complex immunological cases.

Additionally, accelerated options such as the accelerated fnp programs provide a faster path to becoming a Family Nurse Practitioner, ideal for those eager to apply immunology knowledge in primary care settings sooner.

Best Scientists Citing Robert H. Vonderheide

Trending Scientists

Recently Published Articles